Carotid Sinus Hypersensitivity Diagnosis and Management

Epidemiology and Risk Factors

The European Society of Cardiology recommends considering Carotid Sinus Hypersensitivity (CSH) as a clinical marker of widespread arteriosclerotic disease, with a prevalence increasing dramatically with advancing age, affecting up to 39-45% of elderly patients presenting with syncope, falls, or dizziness 1, 2
CSH accounts for approximately 20% of syncope cases in older adults as an attributable cause, with male sex and increasing age being independent predictors 1, 2
The condition is strongly associated with cardiovascular disease, cerebrovascular disease, hypertension, and neurodegenerative comorbidity 1, 2

The American College of Cardiology recognizes three distinct forms of CSH based on the reflex components: cardioinhibitory, vasodepressor, and mixed types 3, 4, 5, 6
Cardioinhibitory type is defined as asystole ≥3 seconds due to sinus arrest or AV block during carotid sinus stimulation, resulting from increased parasympathetic tone causing sinus rate slowing or advanced AV block 3, 4, 5, 6, 7
Vasodepressor type is defined as systolic blood pressure drop ≥50 mmHg independent of heart rate changes, secondary to reduction in sympathetic activity causing loss of vascular tone 3, 4, 5, 6, 7

The European Heart Journal recommends performing carotid sinus massage routinely in all patients >40 years with syncope or unexplained falls when initial evaluation reveals no cause, using continuous ECG and beat-to-beat phasic blood pressure monitoring 1, 2
Diagnostic criteria for Carotid Sinus Syndrome (CSS) include asystole ≥3 seconds, systolic blood pressure drop ≥50 mmHg, and reproduction of spontaneous symptoms during carotid sinus massage 3, 4, 5, 6

The American College of Cardiology recommends permanent dual-chamber cardiac pacing as the treatment of choice for recurrent syncope with documented cardioinhibitory response (Class I recommendation), with pacing reducing syncope recurrence from 57-60% to 5-9% over 1-3.7 years 7, 8
For vasodepressor or mixed CSS, management is challenging, and pacing alone is ineffective; discontinue or reduce chronic vasodilator therapy when possible, and consider alternative therapeutic measures 1, 8
The American College of Cardiology also recommends considering CSH in elderly patients with unexplained falls even without documented loss of consciousness, with pacing significantly reducing the likelihood of subsequent falls in this population 7, 8